Anaplastic Large Cell Lymphoma, ALK-Negative Active Not Recruiting Phase 2 Trials for Methylprednisolone (DB00959)

Also known as: Anaplastic Large Cell Lymphoma, ALK-negative

IndicationStatusPhase
DBCOND0061449 (Anaplastic Large Cell Lymphoma, ALK-Negative)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01719835CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II StudyTreatment